Suven Life Sciences - Quaterly Results

04 Nov 2023 Evaluate
The sales moved down -30.23% to Rs. 30.60 millions for the September 2023 quarter as compared to Rs. 43.86 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2023 of Rs. 27.55 millions grew from Rs.-89.33 millions Operating profit Margin for the quarter ended September 2023 improved to -29.34% as compared to -72.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 30.60 43.86 -30.23 68.57 79.25 -13.48 135.39 118.44 14.31
Other Income 51.42 2.06 2396.12 107.82 6.42 1579.44 84.49 16.01 427.73
PBIDT -29.34 -72.44 -59.50 -40.89 -138.74 -70.53 -192.95 -350.41 -44.94
Interest 0.42 0.69 -39.13 0.93 1.71 -45.61 2.89 5.30 -45.47
PBDT 44.81 -73.13 -161.27 32.75 -80.45 -140.71 -135.84 -318.55 -57.36
Depreciation 17.26 16.20 6.54 33.91 32.01 5.94 65.43 43.93 48.94
PBT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -95.88 -165.16 -41.95 -59.63 -175.07 -65.94 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

133.50 -3.40 (-2.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×